News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Myeloma Paper of the Day, May 2nd, suggested by Robert Orlowski
May 2, 2025, 09:25

Myeloma Paper of the Day, May 2nd, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: dFLC over 180 mg/L may no longer holds prognostic value in era of CyBorD/DaraCyBorD-based AL amyloidosis therapy and question utility of Mayo 2012 staging system in the era of highly effective chemo-immunotherapies.”

Title: Predictive Value of Free Light Chain Burden in Patients with AL Amyloidosis Treated with Bortezomib-Based Regimens

Authors: Brendan Saunders, Foteini Theodorakakou, Despina V Fotiou, Samuel Boullt, Benjamin Evans, Meletios Athanasios Dimopoulos, Efstathios Kastritis, Giada Bianchi.

You can read the Full Article on Blood Advances.

Myeloma Paper of the Day, May 2nd, suggested by Robert Orlowski

More posts featuring Robert Orlowski.

AL Amyloidosis Benjamin Evans Brendan Saunders cancer Despina V Fotiou Efstathios Kastritis Foteini Theodorakakou Giada Bianchi Meletios-Athanasios Dimopoulos Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski Samuel Boullt
Special Coverage
Science
May 2, 2025, 09:25
Myeloma Paper of the Day, May 2nd, suggested by Robert Orlowski
Blog
May 2, 2025, 09:14
ESMO Open - Tumor-Informed ctDNA Assay for Recurrence Prediction in Locally Advanced SCCHN
Blog
May 2, 2025, 09:12
City Cancer Challenge Announces WHA78 Events on Women’s Health and LMIC Cancer Financing
Blog
May 2, 2025, 09:06
Jonathan Friedberg: Comparison of Ide-cel Versus Cilta-cel in Relapsed/Refractory Multiple Myeloma
Insight
May 2, 2025, 08:58
Guillermo Chantada shares retinoblastoma survival progress in Argentina
Science
May 2, 2025, 08:58
Thor Halfdanarson: Routine Surveillance for Cancer Metastases — Does It Help or Harm Patients?
Blog
May 2, 2025, 08:50
Anirban Maitra: Congratulations to Vince Bernard-Pagan on AACR Career Development Award in honor of Congressman John Lewis
Blog
May 2, 2025, 08:39
Maryam Lustberg: Amazing talk by Dr. Patricia Ganz on interventions for behavioral symptoms in cancer survivors
Blog
May 2, 2025, 08:38
Michael Sapienza: The Colorectal Cancer Alliance is Strengthening Its Commitment to Project Cure CRC
Blog
May 2, 2025, 08:37
Duke Radiation Oncology - Guidance on Radiation Therapy a First for Anal Cancer Patients
Blog
May 2, 2025, 08:37
Faiha Bazzeh: Honored to serve as Program Director of KHCC's PHO fellows at POEM's 4th Scientific Meeting
Career
May 2, 2025, 08:35
Andre De Souza has been appointed Director of Genitourinary Medical Oncology at Oklahoma University